C Partners Holding’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,310
Closed -$117K 248
2018
Q3
$117K Sell
1,310
-1,110
-46% -$98.1K 0.04% 166
2018
Q2
$192K Buy
2,420
+218
+10% +$18.1K 0.07% 243
2018
Q1
$196K Sell
2,202
-397
-15% -$38.1K 0.08% 223
2017
Q4
$271K Buy
+2,599
New +$293K 0.11% 145
2015
Q3
Sell
-31,000
Closed -$3.59M 43
2015
Q2
$3.59M Hold
31,000
1.68% 17
2015
Q1
$3.57M Hold
31,000
1.14% 23
2014
Q4
$3.47M Buy
+31,000
New +$3.27M 1.12% 28

Other funds holding CELG

C Partners Holding's CELG Position: Q4 2018 in Review

C Partners Holding sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 1,310 shares — an estimated $117K sold.

C Partners Holding first reported a position in CELG in Q4 2014 and held it in 7 quarters. The position peaked at $3.59M in Q2 2015. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • C Partners Holding reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • C Partners Holding sold 1,310 Celgene Corp shares in Q4 2018, an estimated $117K.
  • C Partners Holding first reported a position in Celgene Corp in Q4 2014 and held it in 7 quarters.
  • C Partners Holding's Celgene Corp position peaked at $3.59M in Q2 2015.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on C Partners Holding's 13F filing for Q4 2018, filed 7 Feb 2019.